Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Waterloo

$65,000.00

Regulation and mechanism of nitric oxide synthase isozymes

FY 2007-08

Summary
Nitric oxide (NO) is one of the most widespread signaling molecules in mammals and important in controlling nearly every cellular and organ function in the body.    Since NO plays multiple physiological roles in regulating varied and diverse organ functions, defects in NO production are also involved in a number of pathophysiological states including atherosclerosis, hypertension, stroke and vascular complications in diabetes.  NO is synthesized in the body by enzymes named nitric oxide synthases or NOS.  NOS enzymes are some of the most complex enzymes ever discovered.  Precise control of NOS enzymes is of potential therapeutic value since NO has diverse biological functions and is also a key part of several serious disease states. A significant number of fundamental questions about NOS need to be answered before we can take full advantage of the therapeutic potential of this target enzyme.  The long-term goals of our research program are to understand the regulation and mechanism of NOS enzymes and the role of NO in cell function, signalling and differentiation.  We use the recombinant forms of the three different mammalian NOS enzymes in our investigations.  Site-directed mutagenesis is used to decipher the role of important regions of the enzymes.  We learn about their fundamental properties by performing experiments on native and mutated forms of the enzymes.  For example, although all three enzymes are activated when bound to a calcium sensing protein called calmodulin, there are significant differences in the processes leading to the activation of each enzyme.  Our research program will provide an understanding of the important mechanism of calmodulin binding and activation of NOS enzymes.  We will also perform in vivo investigations using mammalian cell culture studies to understand how cell function, homeostasis and differentiation  as well as enzyme activity and are affected by the post-translational processing of the inducible NOS enzyme.  Gaining a better understanding of how these enzymes function may help in the development of therapies for a wide variety of diseases.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
183521-2007
Name nom
Guillemette, Guy
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2007
Award amount
65000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
1
Nb partie
5
Application title
Regulation and mechanism of nitric oxide synthase isozymes
Keyword
NA
Application summary
Nitric oxide (NO) is one of the most widespread signaling molecules in mammals and important in controlling nearly every cellular and organ function in the body.    Since NO plays multiple physiological roles in regulating varied and diverse organ functions, defects in NO production are also involved in a number of pathophysiological states including atherosclerosis, hypertension, stroke and vascular complications in diabetes.  NO is synthesized in the body by enzymes named nitric oxide synthases or NOS.  NOS enzymes are some of the most complex enzymes ever discovered.  Precise control of NOS enzymes is of potential therapeutic value since NO has diverse biological functions and is also a key part of several serious disease states. A significant number of fundamental questions about NOS need to be answered before we can take full advantage of the therapeutic potential of this target enzyme.  The long-term goals of our research program are to understand the regulation and mechanism of NOS enzymes and the role of NO in cell function, signalling and differentiation.  We use the recombinant forms of the three different mammalian NOS enzymes in our investigations.  Site-directed mutagenesis is used to decipher the role of important regions of the enzymes.  We learn about their fundamental properties by performing experiments on native and mutated forms of the enzymes.  For example, although all three enzymes are activated when bound to a calcium sensing protein called calmodulin, there are significant differences in the processes leading to the activation of each enzyme.  Our research program will provide an understanding of the important mechanism of calmodulin binding and activation of NOS enzymes.  We will also perform in vivo investigations using mammalian cell culture studies to understand how cell function, homeostasis and differentiation  as well as enzyme activity and are affected by the post-translational processing of the inducible NOS enzyme.  Gaining a better understanding of how these enzymes function may help in the development of therapies for a wide variety of diseases.
University of Waterloo - $65,000 Grant (2007-08) | Canada Spends